Clinical Trials Browser

Phase 2 × Adenocarcinoma, Bronchiolo-Alveolar × MK 2206 × Clear all

NCT01294306 2016-11-29

MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy

Phase 2 Completed

80 enrolled 10 charts

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung